13 C]acetate during a separate visit in a subset of ND (n ϭ 7) subjects. Ratio of 13 C3/ 13 C4 obtained following either tracer was Ͻ1.0 at baseline and during clamp, indicating that TPI exchange was essentially complete and did not contribute to asymmetric glucose enrichment. Uncorrected and corrected rates of gluconeogenesis were no different (P ϭ not significant) in T2DM vs. ND both at baseline and during clamp. TA correction resulted in equivalent estimates of corrected gluconeogenesis in T2DM and ND that were ϳ25-35% lower than uncorrected gluconeogenesis both at baseline and during the clamp. The asymmetric enrichment of glucose from 13 C-gluconeogenic tracers is attributable to TA exchange and can be utilized to correct for TA exchange. In conclusion, TA exchange does not differ between T2DM and ND under fasting or hyperglycemic clamp conditions, and the 2 H2O method continues to provide an accurate estimation of gluconeogenesis. gluconeogenesis; deuterated water; transaldolase; triose phosphate isomerase AFTER AN OVERNIGHT FAST, plasma glucose is not symmetrically labeled from gluconeogenic carbon tracers such as [U-
AFTER AN OVERNIGHT FAST, plasma glucose is not symmetrically labeled from gluconeogenic carbon tracers such as [U- 13 C] glycerol (21) and [3- 14 C]lactate (25). Exchange of fructose 6-phosphate and triose phosphate mediated by transaldolase has been implicated by us (3, 7, 9) and others (12) in overestimation of rates of gluconeogenesis, utilizing the deuterated water method. In this method, glucose derived from glycogenolysis (GGL) via glucose 6-phosphate (G6P) source can become labeled in carbons 4, 5, and 6 from either a carbonlabeled gluconeogenic precursor or deuterated water independent of gluconeogenesis. This results in an overestimation of the gluconeogenic fraction and a corresponding underestimation of the glycogenolytic contribution to endogenous glucose production. This exchange is particularly important in the study of type 2 diabetes mellitus (T2DM) since it mimics the characteristic shift toward increased hepatic gluconeogenic activity during the progression of this disease. With a few exceptions (14) , stable isotope tracer studies indicate an increased fractional gluconeogenesis in overnight-fasted T2DM subjects compared with healthy nondiabetic (ND) controls (6, 10, 15, 16, 28) . Transaldolase (TA) exchange activity has been implicated in both ND and T2DM subjects from the depletion of position 5 relative to position 3 label following metabolism of [3, H 2 ]galactose to glucose (7) . However, it is not known whether transaldolase exchange activity is different between ND and T2DM under conditions of fasting and hyperglycemia (frequently seen with meals). This study was undertaken to compare TA exchange reaction in ND and T2DM subjects using [1- 13 C]acetate infusion under conditions of fasting and during a hyperglycemic moderate-dose insulin clamp to determine whether or not TA exchange activity explains differences in glucose enrichment from gluconeogenic substrates between ND and T2DM subjects.
We have demonstrated that TA activity occurs in healthy humans based on a higher enrichment of glucose carbon 4 over carbon 3 (i.e., 13 C3/ 13 C4 Ͻ 1.0) from [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]acetate (3) . In this study, the asymmetric labeling of glucose from this tracer could also be explained by incomplete exchange of the label between glyceraldehyde 3-phosphate and dihydroxyacetone phosphate mediated by incomplete triose phosphate isomerase (TPI; see Fig. 1 ). When the carbon label is derived from glycerol instead of acetate, incomplete TPI exchange results in the opposite glucose C3/C4 labeling asymmetry (i.e., 13 C3/ 13 C4 Ͼ 1.0), whereas TA activity promotes a higher enrichment of glucose carbon 4 relative to carbon 3 for both tracers (21) . Thus, by comparing glucose 13 C3/ 13 C4 from both acetate and glycerol, the contributions of incomplete TPI exchange and TA activity to the glucose-labeling asymmetry can be resolved.
Therefore, we also compared the 13 C enrichment of glucose from [1- 13 C]acetate and [U- 13 C]glycerol in a subset of ND subjects to determine the extent to which asymmetric glucose C3 and C4 enrichments are determined by incomplete TPI exchange and by TA exchange.
RESEARCH DESIGN AND METHODS
After approval from the Mayo Institutional Review Board was given for our experiments, 11 T2DM and 10 ND subjects gave written informed consent to participate in the study. Data from one T2DM and two ND subjects were excluded from analyses due to insufficient 13 C3 and 13 C4 glucose enrichments for reliable quantification of 13 C3/ 13 C4. All subjects were in good health and at stable weights. None regularly engaged in exercise training programs. None of the first-degree relatives of the healthy subjects had a history of diabetes mellitus. At the time of screening, one of the T2DM subjects was being treated with lifestyle modification alone; eight T2DM subjects were being treated with metformin and two on a combination of a sulfonylurea and metformin. Thiazolidinedione and glucagon-like peptide-1-based therapies were exclusionary. Oral antihyperglycemic medications were discontinued 10 days prior to study. All subjects were instructed to maintain their body weight constant and follow a weight maintenance diet (55% carbohydrate, 30% fat, and 15% protein) Ն2 wk prior to study. Body composition was measured prior to the study visit in the Mayo Center for Translational Science Activities (CTSA) body composition core using Lunar iDXA software version 6.10 (GE Healthcare Technologies, Madison, WI), and waist/hip ratio was measured at screen visit. Subject characteristics are given in Table 1 .
Experimental Design
Subjects were admitted to the clinical research unit of the Mayo CTSA at ϳ1700 on the evening before the study and provided a standard supper (10 calories/kg; carbohydrate/fat/protein, 55:30:15). Subjects then ingested 1.67 g/lean body wt 2 H2O in three equally divided doses at 2200, 2400, and 0200. Thereafter, the subjects were permitted sips of water containing 2 H2O if they so desired but otherwise remained fasting.
Subjects were awakened the following morning and catheters were placed in forearm veins for tracer infusion and sampling of arterialized venous blood as previously described (8 [3- 3 H]glucose was started at time zero and given in amounts sufficient to clamp plasma glucose at ϳ180 mg/dl, as described previously (8) . In addition, the basal infusion of [3- 3 H]glucose was tapered beginning at time zero in a pattern that mimicked the anticipated changes in glucose production to minimize the changes in plasma glucose-specific activity, as described previously (2, 5) .
Analytical Methods
Samples at Ϫ30 and 0 min were combined for baseline and 210 and 240 min for clamp measurements of 2 H and 13 C enrichments by 2 H and 13 C NMR analysis of monoacetone glucose (MAG). All blood samples were immediately placed on ice, centrifuged at 4°C, separated, and stored at Ϫ80°C until analyses. Plasma glucose was analyzed using a GM9 Analox glucose analyzer (Analox Instruments, London, UK). Plasma insulin, C-peptide, and glucagon concentrations and [3- 3 H]glucose-specific activity were measured as described previously (2, 3). 13 C-excess enrichment of glucose carbons 3 and 4 from [1-13 C]acetate was measured by quantitative 13 C and 1 H NMR analysis (see Fig. 2 ) of the MAG derivative, as described previously (19, 20) . 13 C-excess enrichment of glucose carbons 3 and 4 from [U- 13 C]glycerol was measured from partially saturated and no nuclear Overhauser enhancement (nOe-enhanced) proton-decoupled 13 G-6-P G-6-P G-6-P F-6-P F-6-P F-6-P F-B-P F-B-P F-B-P GA3P DHAP NMR spectra by analyzing the carbon 3 and carbon 4 isotopomer signals (see Fig. 3 ). Briefly, the singlet component of each signal was assumed to represent the 1.11% natural abundance 13 C, and the doublet components were assumed to represent 13 C enrichment of plasma glucose from [U-
13 C]glycerol. Excess 13 C enrichment was calculated as the ratio of doublet to singlet multiplied by 1.11% (21) . The 13 C NMR analyses were performed with a BrukerAvance III 600 system equipped with a 5-mm TCP-QNP cold probe. 2 H NMR spectra were acquired at 50°C with a 14.1T Varian VNMR system, as described previously (19, 20 
Calculations
All rates are expressed per lean body mass. Glucose turnover was calculated using the steady-state equations of Steele, as described previously (27) . The fraction of plasma glucose derived from TA exchange was calculated from the ratio of excess glucose carbon 3 to carbon 4 13 C enrichments ( 13 C3/ 13 C4) (3). Endogenous glucose production (EGP) was calculated by subtracting the glucose infusion rate required to maintain hyperglycemia from total glucose appearance. Gluconeogenesis was calculated by multiplying the ratio of deuterium enrichment of positions 5 and 2 of glucose ( 2 H5/ 2 H2) times endogenous glucose production. GGL was calculated by subtracting gluconeogenesis from EGP, as described previously (8) . TAcorrected rates of gluconeogenesis and GGL were calculated as published previously (3, 4) .
Statistical Analysis
Data in the text and figures are expressed as means Ϯ SE. Values from Ϫ30 and 0 min were averaged as basal and at 210 and 240 min as clamp for statistical analysis and representation. Student's paired one-tailed t-test was used to test the hypothesis that plasma glucose 13 C3/ 13 C4 is less than one, and Student's unpaired two-tailed t-test was used to test differences between groups. A P value Ͻ0.05 was considered statistically significant.
RESULTS

Effects of TA Exchange Plasma glucose, insulin, C-peptide, and glucagon concentrations.
Fasting plasma glucose concentrations (Fig. 4 ) were higher (P Ͻ 0.0001) in subjects with T2DM than in ND subjects at baseline (10.74 Ϯ 0.72 vs. 5.34 Ϯ 0.15 mM) but were matched [P ϭ not significant (NS)] during the clamp (10.00 Ϯ 0.52 vs. 9.43 Ϯ 0.13 mM) (Fig. 4) . Fasting insulin concentrations (Fig.  4) were significantly higher (P Ͻ 0.05) in T2DM than in ND subjects at baseline (59.34 Ϯ 7.30 vs. 34.65 Ϯ 5.59 pM) but did not differ (P ϭ NS) during the clamp (134.94 Ϯ 4.64 vs. 126.30 Ϯ 7.99 pM). Similarly, C-peptide concentrations (Fig. 4) were significantly higher (P Ͻ 0 .05) in T2DM than in ND subjects before the clamp (1.32 Ϯ 0.13 vs. 0.97 Ϯ 0.13 nM) but were no different (P ϭ NS) during the clamp (0.16 Ϯ 0.02 vs. 0.16 Ϯ 0.02 nM), indicating that there was suppression of endogenous insulin secretion in both groups. Glucagon concentrations (Fig. 4) were significantly higher (P Ͻ 0 .05) in T2DM than in ND subjects before the clamp (78.67 Ϯ 5.37 vs. 57.56. Ϯ 5.09 nM) and, as expected, were not different (P ϭ NS) during the clamp (65.17 Ϯ 2.71 vs. 56.25 Ϯ 3.20 nM).
Glucose infusion rate and H]glucose-specific activity. The glucose infusion rate (Fig. 5 ) required to maintain hyperglycemia (ϳ10 mM) during the clamp was significantly lower (P Ͻ 0.05) in T2DM than in ND subjects (10.63 Ϯ 3.08 vs. 33.39 Ϯ 8.93 mol·kg Ϫ1 ·min Ϫ1 ) (Fig. 5 ). Plasma H]glucose-specific activity (Fig. 5) remained constant throughout the study in both groups, enabling measurement of glucose fluxes using steady-state equations.
Plasma glucose 13 C enrichments and ratio of 13 C3/ 13 C4 obtained from [1- 13 C]acetate. 13 C NMR spectra of plasma MAG obtained following infusion of [1- 13 C]acetate demonstrate a consistently higher 13 C NMR signal intensity of carbon 4 over carbon 3 (see Fig. 2 and Table 2 ). Since these spectra were acquired under quantitative conditions (i.e., no nuclear Overhauser enhancement during proton decoupling and full relaxation of the 13 C signals between pulses) as in previous studies (3), these data (Table 2) indicate an excess 13 C enrichment of carbon 4 over carbon 3 or ratio of 13 C3/ 13 C4 Ͻ 1.0. This is consistent with TA activity, where unlabeled G6P derived from GGL (under baseline conditions) or a combination of GGL and inflow of plasma glucose (under clamp conditions) is enriched in positions 4, 5, and 6 from labeled trioses. The 2 H enrichment patterns that are revealed by the 2 H NMR spectra also suggest that glucose 13 C enrichment from [1-
13 C]acetate occurs because of TA exchange. For both ND and T2DM groups, there are substantial GGL and GGL/ glucose contributions to EGP under baseline and clamp conditions, respectively, as seen by the ratio of positions 5 and 2 enrichments (Fig. 2 and Table 3 ), thereby providing a significant source of unlabeled G6P for TA exchange.
Rates of EGP and glucose disappearance. Rates of EGP ( (Fig. 6) . Rates of glucose disappearance are equal to glucose production at baseline. Therefore, rates of glucose disappearance (Fig. 6 ) were significantly higher (P Ͻ 0.05) in T2DM than in ND subjects at baseline (19. ). The higher rates of EGP and glucose disappearance in T2DM than in ND subjects at baseline need to be interpreted in the light of higher glucose and insulin concentrations in T2DM during this period. In contrast, when glucose and insulin concentrations were matched between groups during the clamp, there were no statistically significant differences in rates of EGP, but rates of glucose disappearance were lower in T2DM than ND subjects.
Rates of gluconeogenesis and GGL uncorrected and corrected for TA exchange. Corrected rates of gluconeogenesis (Fig. 7 ) in T2DM were lower (P Ͻ 0.05) than uncorrected rates of gluconeogenesis both prior to (7. (Fig. 7) . Corrected rates of gluconeogenesis (Fig. 7) were lower (P Ͻ 0.05) than uncorrected rates of gluconeogenesis prior to (6. ) in ND subjects. The fractional difference between uncorrected and corrected rates of gluconeogenesis were not different (P ϭ NS) between T2DM and ND subjects at baseline or during clamp, suggesting that the contribution of TA exchange to the estimate of fractional gluconeogenesis is no different between groups under these experimental conditions.
Corrected rates of GGL (Fig. 7 ) in T2DM were higher (P Ͻ 0.05) than uncorrected rates of GGL both prior to (12. ) in ND subjects.
Effects of TPI Exchange
Plasma glucose, insulin, C-peptide, and glucagon concentrations. Fasting plasma glucose concentrations (Fig. 4 ) in ND subjects were no different between [1-
13 C]acetate and [U- 13 C]glycerol studies (5.34 Ϯ 0.15 vs. 5.17 Ϯ 0.12 mM, P ϭ NS; Fig. 4) . Similarly, plasma glucose concentrations were also matched during the clamp (9.43 Ϯ 0.13 vs.9.36 Ϯ 0.40 mM, P ϭ NS) on either occasion (Fig. 4) . Plasma insulin concentrations (Fig.  4) were similar (P ϭ NS) on both acetate as well as glycerol study days both prior to (34.65 Ϯ 5.59 vs. 34.80 Ϯ 4.61 pM) and during the clamp (126.30 Ϯ 6.36 vs. 127.97 Ϯ 4.37 pM). Similarly, C-peptide concentrations (Fig. 4) were no different (P ϭ NS) on acetate vs. glycerol study days either before (0.97 Ϯ 0.13 vs. 0.88 Ϯ 0.11 nM) or during the clamp (0.16 Ϯ 0.02 vs. 0.16 Ϯ 0.03 nM), indicating comparable suppression of endogenous insulin secretion on both study days. Glucagon concentrations (Fig. 4) Fig. 5 ) study days. Plasma [3- 3 H]glucose-specific activity (Fig. 5 ) remained constant throughout the study on both days, enabling measurement of glucose fluxes using the steady-state equation.
Plasma glucose 13 13 C NMR spectra of glucose observed showed 13 C enrichment of glucose carbons 3 and 4 as 13 C/ 13 C spin-coupled doublets flanking central singlet carbon 3 and 4 signals, as shown in Fig. 3 . The carbon 4 doublet was further split into two equal components by long-range coupling to carbon 6 (21), consistent with the [4,5,6-13 C 3 ]glucose isotopomer being the principal contributor to carbon 4 13 C enrichment. This was also confirmed by inspection of the carbon 5 and 6 isotopomer signals (data not shown). The monoacetone carbon 3 resonance does not have significant coupling with carbon 1, and hence, the carbon 3 enrichment appeared as a simple doublet, representing nearest-neighbor coupling with carbon 2. Analysis of the carbon 2 multiplet showed that [1,2,3-13 C 3 ]glucose isotopomer constituted the majority (Ͼ80%) of 13 C enrichment of the "upper" triose moiety of glucose and was the principal contributor to carbon 3 excess 13 C enrichment. 13 C3/ 13 C4 ratios were Ͻ1.0 in all ND subjects on glycerol study visit at baseline and during clamp (Table 2 and Fig. 8) . Similarly, 13 C3/ 13 C4 ratio derived from [1- 13 C]acetate observed was also Ͻ1.0 in all ND subjects studied (Fig. 8) and was not significantly different (P ϭ NS) from those obtained with [U- 13 C]glycerol (Table 2 and Fig. 8 ). The concordance of [1-
13 C]acetate-and [U- 13 C]glycerol-derived 13 C3/ 13 C4 values is consistent with TA activity in the setting of nearly complete TPI exchange, as explained in Fig. 1 .
Rates of EGP and glucose disappearance. Rates of endogenous glucose production in ND subjects were no different (P ϭ NS) at baseline (17.53 Ϯ 0.44 vs. 17.38 Ϯ 0.40 mol·kg Ϫ1 ·min Ϫ1 ) on either acetate or glycerol study days (as shown in Fig. 6 ). Similarly, suppression of EGP during clamp was no different (P ϭ NS, 4.27 Ϯ 1.23 vs. 3.33 Ϯ 0.74 mol·kg Ϫ1 ·min Ϫ1 ) on either acetate or glycerol study days (Fig. 6) .
At baseline, EGP equals glucose disappearance. Rates of glucose disappearance were no different (P ϭ NS) prior to clamp (Fig. 6) . During the clamp, rates of glucose disappearance were similar on both acetate vs. glycerol study days (35.85 Ϯ 6.22 vs. 36.58 Ϯ 5.26 mol·kg Ϫ1 ·min Ϫ1 ), suggesting comparable insulin-induced glucose uptake on both occasions (Fig. 6) .
Rates of gluconeogenesis and GGL uncorrected and corrected for TA exchange reaction. Uncorrected and corrected rates of gluconeogenesis in ND subjects were similar (P ϭ NS) Fig. 7 . Contribution of gluconeogenesis (black bars) and glycogenolysis (open bars) to endogenous glucose production (EGP) observed during [1- 13 C]acetate infusion before and during the clamp in healthy and T2DM subjects, calculated using the uncorrected and corrected ratios of the deuterium enrichment on position 5 and position 2 of plasma glucose. *P Ͻ 0.05 vs. uncorrected gluconeogenesis. on acetate and glycerol study days both prior to (9. 
Clamp Baseline
DISCUSSION
The present study demonstrates that TA exchange is equal in people with and without type 2 diabetes both in the overnightfasted state and during matched hyperglycemia and portal insulin concentrations. The deuterated water method is utilized extensively for estimation of rates of gluconeogenesis (1, 6, 11, 13, 15, 17, 26) . Together with glucose tracer methodology, this is important for understanding the progression of type 2 diabetes and for evaluating the effects of various therapeutic strategies (viz., medications) intended to mitigate excessive hepatic glucose production by inhibiting gluconeogenesis. Therefore, validation of tracer-derived gluconeogenesis measurements is possible in principle, for example, by comparison with gluconeogenic fluxes obtained by subtraction of real-time glycogenolysis and EGP (18, 23, 24) , a measurement that is insensitive to TA activity. However, outside of a few specialized clinical research centers, this approach is not available, and in many cases it does not provide reliable estimates of gluconeogenesis under clamp conditions. Therefore, recent studies have focused on the analysis of glucose enrichment from 13 C tracers that are coadministered with 2 H 2 O. Apart from providing a wealth of additional metabolic information for estimating gluconeogenic fluxes in various settings (12, 22, 29) , these tracers also can be used to identify asymmetric enrichment of glucose from TA activity.
A relevant limitation of using [1-13 C]acetate as a tracer for determining TA activity is that the observed glucose 13 C3/ 13 C4 ratio can be explained by incomplete equilibration of the 13 C label into dihydroxyacetone acetone phosphate and glyceraldehyde 3-phosphate pools by TPI, as illustrated in Fig. 1 . To address this, we infused [U- 13 C]glycerol, a tracer that enters the triose phosphate pool distally to [1- 13 C]acetate and would generate glucose with a higher enrichment of carbon 3 over carbon 4 if TPI exchange were incomplete, as shown in Fig. 1 13 C NMR isotopomer analyses are more robust in that the 13 C excess enrichment information is directly obtained from the ratio of different 13 C NMR signals rather than from subtraction of two signals of similar intensities. The precision of isotopomer analysis is limited only by the signal-to-noise ratio of the weaker 13 C signal component of the resonance (usually the multiplet). We chose to measure the C3 and C4 multiplet signals over the others (i.e., C2 vs. C5 or C1 vs. C6) because they provide the highest signal-to-noise ratio for a given 13 [1- 13 C]acetate is consistent with TPI exchange that approaches 100% completion.
As described recently, the effects of TA on measurements of gluconeogenesis by the 2 H 2 O method can be corrected by analyzing 13 C3/ 13 C4 from coadministration of a 13 C tracer (3, 12, 21) . Since equilibration of the 13 C label between glyceraldehyde 3-phosphate and dihydroxyacetone phosphate (DHAP) via TPI is essentially complete, the 13 C tracer can be a DHAP precursor (i.e., [ 13 C]glycerol or dihydroxyacetone) or a glyceraldehyde 3-phosphate precursor ( 13 C-propionate, acetate, or bicarbonate), although glucose enrichment from the latter group is less sensitive to incomplete TPI exchange (21) .
Consistent with our previous observation in healthy humans and in prediabetes (3, 4), we have now observed that a comparable fraction of the hepatic G6P pool also undergoes TA exchange in people with type 2 diabetes. TA exchange explains the labeling asymmetry of plasma glucose from gluconeogenic carbon tracers and contributes to the enrichment of glucose position 5 from 2 H 2 O. The fraction of hepatic G6P that undergoes TA exchange is relatively constant and does not differ with varying degrees of insulin sensitivity, ranging from healthy subjects to highly insulin-resistant patients with established type 2 diabetes, nor with varying doses of insulin (3, 4, 7, 9) . Since the effect of TA exchange on the source of EGP depends on the contribution of glycogenolysis to EGP, its effects are proportionally highest under conditions of abnor-mally high hepatic G6P production from glycogenolysis. For example, if glycogenolysis contributed 75% of EGP and gluconeogenesis 25%, the presence of a modest level of TA exchange activity (20% exchange of hepatic G6P) would result in apparent glycogenolytic and gluconeogenic contributions of 60 and 40%, respectively. In other words, the uncorrected gluconeogenic flux would be 1.6 times higher than the corrected value.
In summary, the present data indicate that infusion of [1-13 C]acetate results in comparable estimates of TA exchange in healthy subjects and in people with type 2 diabetes both in the overnight-fasted state and during acute hyperglycemia with moderate-dose insulin infusion. We also have demonstrated that asymmetric enrichment of glucose from [U- 13 C]glycerol is also consistent with TA activity and nearly complete TPI exchange. Together with our current and previous observations and those of others, these data provide strong evidence that TA exchange results in a significant fraction of glycogenolytic G6P (15-35%) becoming enriched in position 5 from 2 H 2 O, resulting in a modest overestimation of fractional gluconeogenesis and underestimation of glycogenolytic contribution to EGP. However, this exchange activity is equivalent for healthy, prediabetic, and T2DM subjects and therefore does not explain differences in gluconeogenic and glycogenolytic fluxes between these subject groups. However, it may contribute to the variability in these flux estimates within each subject group. Thus, the 2 H 2 O method continues to provide reliable estimates for quantifying gluconeogenesis and glycogenolysis in various physiological and pathophysiological states.
